Holen Sie sich die Stockscreener-App
1.82
1.09%
-0.02
Handel nachbörslich:
1.81
-0.01
-0.55%
Spectral Ai Inc Aktie (MDAI) Neueste Nachrichten
China's Top Multispectral AI Firm Shenzhen HQVT Advances Hong Kong IPO - TradingView
Number of shareholders of Spectral AI, Inc. – NASDAQ:MDAIW - TradingView
Spectral AI joins wound healing awareness campaign - Investing.com
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month - The Manila Times
Spectral AI Celebrates Wound Healing Awareness Month in Partnership with ABWM Foundation - Quiver Quantitative
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound ... - Enidnews.com
Spectral AI to Participate in 2026 British Burn Association Annual Conference - The Manila Times
AI burn device gauges healing in 21 days at British Burn meet - Stock Titan
SPECTRAL AI INC (MDAI) Stock Chart - ChartMill
FDA clears Spectral AI (Nasdaq: MDAI) DeepView burn system as shareholders back all 2026 proposals - Stock Titan
Spectral AI (MDAI) director DiMaio reports new stock grants and options - Stock Titan
Spectral AI Announces Voting Results of Annual Meeting of Stockholders - The Manila Times
AI burn-scan cleared by FDA as Spectral AI targets first sales - Stock Titan
MDAI: DeepView FDA Clearance Fires Up Our Valuation - Yahoo Finance
Spectral AI Receives FDA Clearance for DeepView Burn System - D Magazine
Spectral AI, Inc.Warrants (NQ: MDAIW - FinancialContent
FDA Grants De Novo OK to Spectral AI’s DeepView System - Medical Product Outsourcing
Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI), NeOnc Technologies Holdings, Inc. (NTHI) and Innoviva (INVA) - The Globe and Mail
Spectral AI (NASDAQ: MDAI) director granted 32,233 shares and holds options - Stock Titan
Spectral AI Inc. (MDAI) Edges Lower as Stock Consolidates Near Support ZoneIchimoku Cloud - thelegaladvocate.com
MDAI Maintained by BTIG -- Price Target Raised to $4.00 - GuruFocus
Spectral AI, Inc. [MDAI NQ]: FDA De Novo Classification granted for DeepView® system for burn indication - London South East
FDA clears Spectral AI (NASDAQ: MDAI) DeepView burn device - Stock Titan
Spectral AI (MDAI) Receives FDA De Novo Classification for DeepV - GuruFocus
BTIG raises Spectral AI stock price target to $4 on FDA clearance - Investing.com Nigeria
BTIG raises Spectral AI stock price target to $4 on FDA clearance By Investing.com - Investing.com South Africa
Spectral AI receives FDA De Novo clearance for burn wound system By Investing.com - Investing.com South Africa
Spectral AI receives FDA De Novo clearance for burn wound system - Investing.com
Spectral Ai Receives FDA De Novo Clearance for DeepView System for Burn Indication - marketscreener.com
AI imaging system now helps doctors judge burn healing in under 30 seconds - Stock Titan
Spectral Ai receives FDA De Novo clearance for Deepview® system for burn indication - marketscreener.com
Spectral Ai Receives FDA De Novo Clearance For Deepview® System For Burn Indication - TradingView
Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication - GlobeNewswire
Spectral AI Q1 earnings call highlights - MSN
Wiley expands mass spectral database to support AI-assisted chemical analysis - Wiley Analytical Science
Spectral AI (MDAI) director awarded 25,000 shares and reports vested options - Stock Titan
Spectral AI (NASDAQ: MDAI) director granted additional common shares and options - Stock Titan
Spectral AI (MDAI) director granted additional common shares and options - Stock Titan
MDAI Technical Analysis & ETF Price Forecast - Intellectia AI
Earnings call transcript: Spectral AI Q1 2026 reveals mixed results, stock dips - Investing.com Nigeria
Analyst Estimates: Here's What Brokers Think Of Spectral AI, Inc. (NASDAQ:MDAI) After Its First-Quarter Report - simplywall.st
MDAI: First Quarter 2026 Results - Yahoo Finance
BTIG Maintains Spectral AI(MDAI.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Spectral AI reports net loss of USD 3.4M in Q1 2026 - Medical Buyer
Spectral AI, Inc. 2026 Q1 Financial Report: DeepView Burn Diagnostics, Financial Results, and Risk Analysis - Minichart
Spectral AI Q1 Earnings Call Highlights - inkl
MDAI: FDA response and BARDA funding drive 2026 outlook; DeepView commercialization targeted late 2026 - TradingView
MDAI: FDA response and DeepView commercialization expected in 2026; BARDA funding drives growth - TradingView
1.21%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):